Skip to content
knowrare
HealthSignal
Your condition community

Living with 3-Methylglutaconic aciduria type 3

A rare inherited metabolic condition that affects vision and movement, with optic nerve damage and involuntary movements.

Understanding 3-Methylglutaconic aciduria type 3

3-Methylglutaconic aciduria type 3 is a rare condition that combines optic atrophy and involuntary movements with an acid in the urine.

It is an organic aciduria. The key features are optic atrophy (damage to the nerve that carries vision from the eye to the brain) and choreoathetosis (slow, writhing involuntary movements). People also have 3-methylglutaconic acid in their urine. GARD lists onset as childhood.

Signs & symptoms

Symptoms vary from person to person. GARD lists these among the most common:

  • Visual impairment
  • Involuntary writhing movements (choreoathetosis)
  • Balance and coordination problems (ataxia)
  • Leg stiffness (spastic paraparesis)
  • Involuntary eye movements (nystagmus)
  • Difficulty with clear speech (dysarthria)

Not everyone has every symptom. GARD's list comes from the Human Phenotype Ontology.

Diagnosis

  1. Talk with your doctor

    Share the symptoms you've noticed, when they started and your family health history. Notes and photos can help.

  2. See a specialist

    Specialists who may be involved include eye disease specialists and genetic specialists.

  3. Consider genetic testing

    Changes in OPA3 are linked to this condition. Genetic testing and counseling can help confirm a diagnosis and explain what it means for your family.

Care & treatment

Care team
Eye disease specialists (ophthalmologists); Genetic specialists (geneticists)
Expert care
Ask about multidisciplinary care centers for rare conditions
Treatment
GARD doesn't list specific treatments for this condition. Your care team will tailor care to your symptoms.
Research
Clinical trials and observational studies may be options. See the research section below.

General information, not medical advice. Your care team makes the decisions.

Everyday life

Living with a rare condition is easier with support.

  • Connect with Organic Acidemia Association
  • Keep notes on symptoms, changes and questions for appointments
  • Ask about patient registries that help research
  • Look into financial aid and travel resources for care visits
Bring these questions to your next doctor visit
How often should my child have eye and vision exams?
What therapies can help with movement and speech?
Should relatives have OPA3 genetic testing?

Quick facts

Symptoms usually startChild
InheritanceAutosomal Recessive
GenesOPA3

Changes in the OPA3 gene cause this condition. It is autosomal recessive, so a child inherits a changed copy of the gene from each parent.

GeneticInherited Metabolic

Also known as: 3-methylglutaconic aciduria caused by mutation in opa3; 3-methylglutaconic aciduria type iii; autosomal recessive optic atrophy plus syndrome; autosomal recessive optic atrophy type 3; costeff optic atrophy syndrome; costeff syndrome

Patient organizations

Source: NIH GARD · 3-Methylglutaconic aciduria type 3GARD ID 5663 · GARD page updated September 2026 · Plain-language summary by Know Rare; editorial review pending. General information, not medical advice.

You are more than your diagnosis

Perspectives from people navigating life with 3-Methylglutaconic aciduria type 3.

Explore the 3-Methylglutaconic aciduria type 3 blog

Explore research for 3-Methylglutaconic aciduria type 3

Explore actively recruiting 3-Methylglutaconic aciduria type 3 studies with HealthSpark.

HealthSpark

Find actively recruiting studies for 3-Methylglutaconic aciduria type 3 with HealthSpark. Share your city to explore research near you.

  • Recruiting studies from ClinicalTrials.gov
  • Share your city to look for research near you
  • Eligibility is confirmed by the study team

Powered by HealthSpark, our AI chat helper

I can help you find recruiting 3-Methylglutaconic aciduria type 3 studies. Enter a ZIP code, address or city below and I'll look within 50 miles.

Powered by HealthSpark, our AI chat helper · Study information from ClinicalTrials.gov · Eligibility is confirmed by the study team.

Get Signals for 3-Methylglutaconic aciduria type 3

Stay in the loop with community stories and updates from medical researchers.

HealthStoryfor 3-Methylglutaconic aciduria type 3

Create a living journal that talks back

HealthStory evolves private journaling with a living AI journal that talks back and asks thoughtful questions, helping you capture your 3-Methylglutaconic aciduria type 3 experiences more deeply and prepare for better conversations with your doctors and care team.

Start your journal

Your journal is private. Sharing your story publicly is a separate choice, made with Share your story above.